Latest News

Nominations are Now Open for the 2023 Canadian Cardiovascular Society Recognition Awards

March 24, 2023

The CCS is proud to recognize members for outstanding contributions to the field of cardiovascular...

Shortage of Nitroglycerin Sprays in Canada 

March 17, 2023

We are notifying you of a pending national shortage of Nitroglycerin spray. Health Canada is...

The Vascular 2023 Call for Science is Live!

March 2, 2023

Take advantage of this opportunity to showcase your work on the Vascular 2023 stage. Seven host...

Our French Name has Changed!

December 22, 2022

It’s official! We now have a new French name!

Fostering equity, diversity and inclusion in all areas of our work – Watch our video

December 22, 2022

The success of the CCS mission depends on people who provide a diversity of backgrounds,...

Call to Action: Contribute to the CCS Vaccine-Associated Myocarditis Study

December 22, 2022

The CCS is actively recruiting cardiac care centres, cardiology clinics and cardiologists from...

Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination

October 27, 2022

Today, at the Canadian Cardiovascular Congress where more than 1200 cardiovascular specialists and...

Two classes of glucose-lowering drugs reduce risk of heart failure, kidney complications and death – even in patients without type 2 diabetes

September 30, 2022

New Cardiorenal Protection Guideline urges use of GLP-1RA and SGLT2i drugs to save lives; as many as...

2023 Call for CCS Guideline and Clinical Practice Update Topics – NOW LIVE!

September 16, 2022

The CCS welcomes Seema Nagpal as our new Chief Science Officer

September 7, 2022

The Canadian Cardiovascular Society is pleased to announce that we are growing our leadership team...